The effects of progesterones on blood lipids in hormone replacement therapy
Open Access
- 21 November 2017
- journal article
- review article
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 16 (1) , 219
Abstract
The safety of progestogens as a class has drawn much attention after the publication of data from the Women’s Health Initiative (WHI) trial, particularly with respect to cardiovascular disease. Depending on the chemical structure, pharmacokinetics, receptor affinity and potency of action, progestogens have a divergent range of properties that may translate to very different clinical effects. The purpose of this review is to describe the role of varied progestogens in hormone replacement therapy (HRT), especially focusing on blood lipids, which are the most important parameters for assessing cardiovascular disease risk.Keywords
This publication has 81 references indexed in Scilit:
- Effects of micronized progesterone added to non-oral estradiol on lipids and cardiovascular risk factors in early postmenopause: a clinical trialLipids in Health and Disease, 2012
- Progesterone receptors, their isoforms and progesterone regulated transcriptionMolecular and Cellular Endocrinology, 2012
- Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolismThe European Journal of Contraception & Reproductive Health Care, 2011
- Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older womenMenopause, 2011
- Premature menopause or early menopause: Long-term health consequencesMaturitas, 2010
- Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one‐year studyActa Obstetricia et Gynecologica Scandinavica, 2004
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Effect on plasma lipids and lipoproteins of postmenopausal oestrogen therapy with added dydrogesteroneBJOG: An International Journal of Obstetrics & Gynaecology, 1990
- Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement TherapyNew England Journal of Medicine, 1981